key: cord-1017700-x64zft78 authors: Zaigham, Mehreen; Andersson, Ola title: Maternal and perinatal outcomes with COVID‐19: A systematic review of 108 pregnancies date: 2020-04-20 journal: Acta Obstet Gynecol Scand DOI: 10.1111/aogs.13867 sha: ad37bd42780cd289f7054a6e10d5a30d156e5d6b doc_id: 1017700 cord_uid: x64zft78 INTRODUCTION: The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has exposed vulnerable populations to an unprecedented global health crisis. The knowledge gained from previous human coronavirus outbreaks suggests that pregnant women and their fetuses are particularly susceptible to poor outcomes. The objective of this study was to summarize the clinical manifestations and maternal and perinatal outcomes of COVID‐19 during pregnancy. MATERIAL AND METHODS: We searched databases for all case reports and series from 12 February to 4 April 2020. Multiple terms and combinations were used including COVID‐19, pregnancy, maternal mortality, maternal morbidity, complications, clinical manifestations, neonatal morbidity, intrauterine fetal death, neonatal mortality and SARS‐CoV‐2. Eligibility criteria included peer‐reviewed publications written in English or Chinese and quantitative real‐time polymerase chain reaction (PCR) or dual fluorescence PCR‐confirmed SARS‐CoV‐2 infection. Unpublished reports, unspecified date and location of the study or suspicion of duplicate reporting, cases with suspected COVID‐19 that were not confirmed by a laboratory test, and unreported maternal or perinatal outcomes were excluded. Data on clinical manifestations, maternal and perinatal outcomes including vertical transmission were extracted and analyzed. RESULTS: Eighteen articles reporting data from 108 pregnancies between 8 December 2019 and 1 April 2020 were included in the current study. Most reports described women presenting in the third trimester with fever (68%) and coughing (34%). Lymphocytopenia (59%) with elevated C‐reactive protein (70%) was observed and 91% of the women were delivered by cesarean section. Three maternal intensive care unit admissions were noted but no maternal deaths. One neonatal death and one intrauterine death were also reported. CONCLUSIONS: Although the majority of mothers were discharged without any major complications, severe maternal morbidity as a result of COVID‐19 and perinatal deaths were reported. Vertical transmission of the COVID‐19 could not be ruled out. Careful monitoring of pregnancies with COVID‐19 and measures to prevent neonatal infection are warranted. such as cytokines and the complement cascade can have deleterious consequences for brain development and function. 7 To find out whether an infectious agent can infect the fetus or newborn by vertical transmission is therefore of particular interest. 8 Pregnant women and their newborns should be evaluated for being potential risk groups in the current COVID-19 pandemic. From the limited information gathered about the novel coronavirus and the drastically increasing burden of the disease, 9 it is vital that scientific information concerning the disease is shared in a concise and practical manner. Data on the maternal and perina- We conducted a comprehensive literature search using MEDLINE, Embase and Google Scholar. The search covered the period from 8 December 2019 through 4 April 2020. We used combinations of the following search terms: COVID-19, pregnancy, maternal mortality, maternal morbidity, complications, clinical manifestations, neonatal morbidity, intrauterine fetal death, neonatal mortality and SARS-CoV-2. Titles and abstracts were reviewed by both the authors to evaluate their relevance to our study. We identified several case reports and case series. Full-text articles were retrieved for further consideration for inclusion. Eligibility criteria included laboratory-confirmed COVID-19 infection using quantitative real-time polymerase chain reaction (qRT-PCR) or dual fluorescence polymerase chain reaction (PCR), patient pregnant on admission, reports written in English or Chinese, and availability of clinical characteristics including maternal and perinatal outcomes. Published guidelines on systematic reviews recommend a quality assessment of the included literature, but since only a handful of case reports and series were available, the authors decided to include as many studies that fitted the eligibility criteria as possible. Two studies where the full-text was written in Chinese were translated with the help of a Chinese translator who worked in the medical profession. Exclusion criteria were as follows: unpublished reports, unspecified date and location of the study or suspicion of duplicate reporting, cases with suspected COVID-19 that were not confirmed by a laboratory test, and unreported maternal or perinatal outcomes. Efforts were made to ensure that there was no overlap in the results and that no case was counted twice. This assessment was based on several criteria as described by Thornton considerable heterogeneity between the studies and factors such as publication bias and selective reporting of the results could not be accounted for. This systematic review did not have a "stand alone" study protocol. We followed the PRISMA guidelines 12 when reporting outcomes for the current study. Chen et al, 13 Liu et al, 14 Li et al, 15 Fan et al, 16 Zhu et al, 17 Wang et al, 18 Chen et al, 19 Zambrano et al, 20 Wang et al, 21 Gidlöf et al, 22 Yu et al, 23 Breslin et al, 24 Iqbal et al, 25 Statistical analysis was done with SPSS, version 25.0 (IBM Corp.). Continuous variables were expressed as mean with standard deviation. Categorical variables were expressed as number of cases and percentages (%). Eighteen studies were screened for the eligibility criteria and included in the current systematic review. The results from 14 case reports are summarized together to facilitate interpretation. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] These were published from 7 March 2020 through 1 April 2020. Data related to the clinical manifestations of COVID-19 at admission including laboratory testing and maternal and perinatal characteristics are presented in Table 1 . The remaining case series [27] [28] [29] [30] were published in 1-8 March 2020 and data were described collectively in cohorts. We therefore report these data in separate columns ( A total of 108 pregnant women with COVID-19 were identified. The majority of the studies originated from China, but cases from Sweden, USA, Korea and Honduras were also included. One of the cases was a premature twin delivery; 17 however, since the maternal qRT-PCR was negative, this case was excluded from the study. Gidlöf et al 22 reported another twin delivery and as the mother had a positive qRT-PCR, the neonates counted for two separate cases in the perinatal data. We made an overall judgement of the quality of the reports included in the analysis based on the questions deemed most critical. In the domain "selection" there was wide variation, ranging from case reports involving only one case to small case series, but authors generally aimed to report all cases known and the overall quality was assessed to be medium. For "ascertainment", exposure and outcome should be adequately ascertained, which was deemed high by both authors. As for the "causality", the case reports could not rule out alternative causes that might explain the observations, no challenge/re-challenge was possible and follow up was short, which rendered a judgement of low-quality. Finally, the cases described were of varied but mostly sufficient detail, rendering a medium quality in the domain "reporting". Mean maternal age ranged from 29 to 32 years of age and women reported mostly in their third trimester. Twenty-two pregnant women (20%) presented in earlier gestational weeks and were discharged, undelivered, without any major complications. However, we identified only four cases where corticosteroids were administered (4 of 28 available cases). From the reasoning provided in the published papers, corticosteroid administration was given to relieve inflammation due to maternal pneumonia rather than for fetal lung maturation. Regarding the perinatal outcomes, most authors 13 There was one case of intrauterine fetal death and one case of neonatal death (Table 1) tive qRT-PCR in both the mother and the neonate. The mother was admitted with fever at 40 weeks of gestation and computerized tomography (CT) scan of chest showed ground-glass opacities in the lungs. She underwent emergency cesarean section and the baby was born with normal Apgar scores. The mother wore an N95 mask during the surgery, and the baby had no contact with the mother after birth and was transferred to the neonatology department 10 minutes after birth for observation. The neonate had lymphocytopenia, deranged liver function and elevated creatine kinase, although it was clinically stable and appeared well. The mother's pharyngeal swab was positive for SARS-CoV-2 and, as a result, a pharyngeal swab was collected from the baby 36 hours after birth. This turned out to be positive. Swabs from umbilical cord blood and placenta were negative, but a possible mother-to-child transmission of SARS-CoV-2 cannot be excluded. Both mother and child recovered and were discharged. Professor Jim Thornton is acknowledged for his helpful suggestions for screening studies for overlap/double reporting of cases and Ahsan Zamir for help with translation of the studies written in Chinese. The authors have stated explicitly that there are no conflicts of interest in connection with this article. Mehreen Zaigham https://orcid.org/0000-0003-0129-1578 Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature Pneumonia in pregnancy Cardio-respiratory physiological adaptation of pregnancy Handbook of Obstetric Medicine Human perinatal immunity in physiological conditions and during infection Advantages and limitations of the neonatal immune system Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China Covid-19 in Pregnancy Methodological quality and synthesis of case series and case reports Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China. Emerg Infect Dis Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry? Clin Infect Dis. 2020. pii: ciaa226 Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia A case report of neonatal COVID 19 infection in China Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia A pregnant woman with COVID-19 in Central America A case of 2019 novel coronavirus in a pregnant woman with preterm delivery COVID-19 in pregnancy with comorbidities: more liberal testing strategy is needed Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study COVID-19 in pregnancy: early lessons An uncomplicated delivery in a patient with covid-19 in the United States Emergency cesarean section on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmed patient Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis Antibodies in infants born to mothers with COVID-19 pneumonia Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn Can SARS-CoV-2 infection be acquired in utero? More definitive evidence is needed Clinical features of patients infected with 2019 novel coronavirus in Wuhan World Health Organization. Novel Coronavirus -China Novel corona virus disease (COVID-19) in pregnancy: what clinical recommendations to follow? Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes